| 1XMY | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | CME, MG, ROL, ZN BindingDB | enzyme |
| ||||||||||||
| related structures | by homologous chain: 1XOT, 1Y2H | ||||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Structural basis for the activity of drugs that inhibit phosphodiesterases., Card GL, England BP, Suzuki Y, Fong D, Powell B, Lee B, Luu C, Tabrizizad M, Gillette S, Ibrahim PN, Artis DR, Bollag G, Milburn MV, Kim SH, Schlessinger J, Zhang KY, Structure (Camb) 2004 Dec;12(12):2233-47. PMID:15576036 | ||||||||||||||
| Data retrieval |
![]() |
| View 1XMY in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |